Compare ALEMBIC LTD with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs AJANTA PHARMA - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD AJANTA PHARMA ALEMBIC LTD/
AJANTA PHARMA
 
P/E (TTM) x 52.3 31.9 164.0% View Chart
P/BV x 4.5 6.6 67.8% View Chart
Dividend Yield % 0.2 0.5 42.6%  

Financials

 ALEMBIC LTD   AJANTA PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
AJANTA PHARMA
Mar-19
ALEMBIC LTD/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs721,422 5.1%   
Low Rs34898 3.8%   
Sales per share (Unadj.) Rs4.7233.5 2.0%  
Earnings per share (Unadj.) Rs6.144.0 13.9%  
Cash flow per share (Unadj.) Rs6.252.2 12.0%  
Dividends per share (Unadj.) Rs0.209.00 2.2%  
Dividend yield (eoy) %0.40.8 48.7%  
Book value per share (Unadj.) Rs40.7255.1 15.9%  
Shares outstanding (eoy) m267.0388.02 303.4%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x11.35.0 226.8%   
Avg P/E ratio x8.726.4 32.9%  
P/CF ratio (eoy) x8.522.2 38.1%  
Price / Book Value ratio x1.34.5 28.6%  
Dividend payout %3.320.5 16.0%   
Avg Mkt Cap Rs m14,139102,081 13.9%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m2074,307 4.8%   
Avg. sales/employee Rs ThNM3,022.6-  
Avg. wages/employee Rs ThNM633.4-  
Avg. net profit/employee Rs ThNM569.1-  
INCOME DATA
Net Sales Rs m1,25520,554 6.1%  
Other income Rs m370211 175.6%   
Total revenues Rs m1,62520,765 7.8%   
Gross profit Rs m1115,664 2.0%  
Depreciation Rs m38721 5.2%   
Interest Rs m212 14.7%   
Profit before tax Rs m4425,143 8.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m241,273 1.9%   
Profit after tax Rs m1,6303,870 42.1%  
Gross profit margin %8.927.6 32.1%  
Effective tax rate %5.424.8 21.9%   
Net profit margin %129.818.8 689.7%  
BALANCE SHEET DATA
Current assets Rs m1,86711,812 15.8%   
Current liabilities Rs m5913,776 15.7%   
Net working cap to sales %101.639.1 260.0%  
Current ratio x3.23.1 101.0%  
Inventory Days Days9477 121.8%  
Debtors Days Days7482 90.1%  
Net fixed assets Rs m1,79114,398 12.4%   
Share capital Rs m534175 304.5%   
"Free" reserves Rs m10,32422,277 46.3%   
Net worth Rs m10,85822,452 48.4%   
Long term debt Rs m417 624.2%   
Total assets Rs m11,59126,962 43.0%  
Interest coverage x260.9444.3 58.7%   
Debt to equity ratio x00 1,290.8%  
Sales to assets ratio x0.10.8 14.2%   
Return on assets %14.114.4 97.8%  
Return on equity %15.017.2 87.1%  
Return on capital %15.223.0 66.2%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1910,682 0.2%   
Fx outflow Rs m2642,102 12.6%   
Net fx Rs m-2448,580 -2.8%   
CASH FLOW
From Operations Rs m2363,748 6.3%  
From Investments Rs m-224-2,228 10.1%  
From Financial Activity Rs m-27-1,475 1.8%  
Net Cashflow Rs m-1545 -32.7%  

Share Holding

Indian Promoters % 64.0 73.8 86.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 1.6 12.9%  
FIIs % 9.7 7.6 127.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 17.0 153.5%  
Shareholders   54,701 20,968 260.9%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  WOCKHARDT  GSK PHARMA  PANACEA BIOTECH  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Metal and Telecom Stocks Witness Buying(Closing)

Indian share markets continued to trade on a volatile note and ended on a flat note today. At the closing bell, the BSE Sensex stood lower by 24 points (down 0.1%).

Related Views on News

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY20); Net Profit Down 7.2% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 7.2% YoY). Sales on the other hand came in at Rs 6 bn (up 18.1% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 8.4% (Quarterly Result Update)

Aug 2, 2019 | Updated on Aug 2, 2019

For the quarter ended June 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 8.4% YoY). Sales on the other hand came in at Rs 6 bn (up 19.8% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

My Best Trading Ideas When Interest Rates Are So Low(Fast Profits Daily)

Jul 23, 2020

India's interest rates are lower than the inflation rate. Here are the best trades for this situation.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Gold or Silver: Which One Should You Buy Now?(Fast Profits Daily)

Jul 24, 2020

Silver and gold are both vying for your attention. Which is the better trade today?

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 5, 2020 03:37 PM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS